Le Lézard
Classified in: Health, Business
Subjects: LIC, MAT

Numinus Announces Agreement with HealingMaps to Drive Strategic Clinic Growth


VANCOUVER, BC, June 22, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) ? a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it has signed an agreement (the "Agreement") with HealingMaps ? a source for individuals looking for accurate and honest information about psychedelic-assisted therapy ("PAT"), to increase awareness of Numinus' wellness clinics and the Numinus Network licensing model, and to offer practitioner training information and referrals ? exclusively to Numinus.

"At its core, HealingMaps connects people seeking mental health treatment options with trusted and qualified clinics and practitioners in their region, and they've established significant traction across our sector. We're pleased to partner with them to drive greater awareness of our services and clinic locations," said Payton Nyquvest, Founder and CEO. "Their data will also help us identify regions with unmet demand for PAT services, as we look to expand our clinic network ? both through corporately owned locations, and those joining our platform through our Numinus Network licensing program."

Cory Jones, CEO and Co-Founder of HealingMaps added: "Numinus has established itself as the leader in the psychedelics sector ? providing much needed clinical infrastructure and practitioner training, along with a growing clinic network across North America. We're honored to work closely with them going forward, to help identify, analyze and support key markets for expansion, as they look to rapidly grow their clinic footprint and client reach over the next several years."

The HealingMaps website generates more than 300,000 organic visitors per month. As part of the Agreement, Healing Maps will showcase Numinus services and clinics on their platform, and engage with practitioners interested in participating in the Numinus Network as licensees, or furthering their PAT training through Numinus' practitioner PAT certification programs. Numinus will also benefit from aggregated market intelligence about growing interest and demand in PAT treatments across regions of North America.

To learn more about Numinus' Practitioner Training programs, including Certification Pathways for Ketamine, MDMA or Psilocybin-assisted therapies, please see: www.numinus.com/our-training-selection/.

To learn more about HealingMaps and their showcase of Numinus' practitioner training services, please see: www.healingmaps.com/psychedelic-assisted-therapy-training/.

About Numinus

Numinus Wellness Inc. (TSX: NUMI; OTCQX: NUMIF) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedInFacebookTwitter, and Instagram.

About HealingMaps

HealingMaps was created as a source for individuals looking for accurate and honest information about psychedelic-assisted therapy (including integrative mental health, ketamine clinics across the United States as well as retreats globally) and qualified providers in their area. Inspired by the groundbreaking research and expanding access to treatment, HealingMaps is on a journey to become the world's most informative and trusted psychedelic-therapy search site.

Forward-looking statements

Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements, including but not limited to launch and commercialization of the partnership with Healing Maps; success of referrals under the Agreement, if any; reliance on professional corporations or similar vehicles in jurisdictions where one is required to deliver health services; uptake of the certification pathway; timing and/or availability of certification pathway training; continued legal availability of experiential component of training or availability of licensed practitioners or professional corporations to deliver the same as part of the certification pathway training; the effect, if any, of having obtained certification on any particular trainee or such trainee's business or profile; the successful launch and commercialization of the Numinus Network, uptake of the Numinus Network offering by practitioners, commercial viability of any or all of the Numinus Network members, availability or continued availability of the services to be delivered to Numinus Network members, client uptake of services from members of the Numinus Network; and the risks set forth in the Company's annual information form dated December 12, 2022 and available on SEDAR at www.sedar.com. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

SOURCE Numinus Wellness Inc.


These press releases may also interest you

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...



News published on and distributed by: